Hypertrophic Cardiomyopathy Without Hypertrophy An Emerging Pre-Clinical Subgroup Composed of Genetically Affected Family Members

被引:18
作者
Maron, Barry J. [1 ]
Ho, Carolyn Y.
机构
[1] Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, Minneapolis, MN 55407 USA
关键词
echocardiography; cardiomyopathy; hypertrophy; LEFT-VENTRICULAR HYPERTROPHY; BINDING PROTEIN-C; ALPHA-MHC403/+ MOUSE MODEL; ABNORMALITIES; GENE; MUTATION;
D O I
10.1016/j.jcmg.2008.09.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:65 / 68
页数:4
相关论文
共 21 条
[1]   The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands [J].
Alders, M ;
Jongbloed, R ;
Deelen, W ;
van den Wijngaard, A ;
Doevendans, P ;
Ten Cate, F ;
Regitz-Zagrosek, V ;
Vosberg, HP ;
van Langen, I ;
Wilde, A ;
Dooijes, D ;
Mannens, M .
EUROPEAN HEART JOURNAL, 2003, 24 (20) :1848-1853
[2]   Altered crossbridge kinetics in the αMHC403/+ mouse model of familial hypertrophic cardiomyopathy [J].
Blanchard, E ;
Seidman, C ;
Seidman, JG ;
LeWinter, M ;
Maughan, D .
CIRCULATION RESEARCH, 1999, 84 (04) :475-483
[3]   Usefulness of Doppler myocardial imaging for identification of mutation carriers of familial hypertrophic cardiomyopathy [J].
Cardim, N ;
Perrot, A ;
Ferreira, T ;
Pereira, A ;
Osterziel, KJ ;
Reis, RP ;
Correia, JFM .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (02) :128-132
[4]   An abnormal Ca2+ response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy [J].
Fatkin, D ;
McConnell, BK ;
Mudd, JO ;
Semsarian, C ;
Moskowitz, IGP ;
Schoen, FJ ;
Giewat, M ;
Seidman, CE ;
Seidman, JG .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (11) :1351-1359
[5]   The pathogenesis of familial hypertrophic cardiomyopathy:: Early and evolving effects from an α-cardiac myosin heavy chain missense mutation [J].
Georgakopoulos, D ;
Christe, ME ;
Giewat, M ;
Seidman, CM ;
Seidman, JG ;
Kass, DA .
NATURE MEDICINE, 1999, 5 (03) :327-330
[6]   Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy [J].
Ho, CY ;
Sweitzer, NK ;
McDonough, B ;
Maron, BJ ;
Casey, SA ;
Seidman, JG ;
Seidman, CE ;
Solomon, SD .
CIRCULATION, 2002, 105 (25) :2992-2997
[7]   PHENOTYPIC SPECTRUM AND PATTERNS OF LEFT-VENTRICULAR HYPERTROPHY IN HYPERTROPHIC CARDIOMYOPATHY - MORPHOLOGIC OBSERVATIONS AND SIGNIFICANCE AS ASSESSED BY 2-DIMENSIONAL ECHOCARDIOGRAPHY IN 600 PATIENTS [J].
KLUES, HG ;
SCHIFFERS, A ;
MARON, BJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (07) :1699-1708
[8]   Hypertrophic cardiomyopathy - A systematic review [J].
Maron, BJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (10) :1308-1320
[9]   Introduction: Eligibility recommendations for competitive athletes with cardiovascular abnormalities-general considerations [J].
Maron, BJ ;
Zipes, DP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (08) :1318-1321
[10]   Clinical course of hypertrophic cardiomyopathy with survival to advanced age [J].
Maron, BJ ;
Casey, SA ;
Hauser, RG ;
Aeppli, DM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (05) :882-888